© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
Ahmed, Mehreen; Jinks, Nicholas; Babaei-Jadidi, Roya; Kashfi, Hossein; Castellanos-Uribe, Marcos; May, Sean T; Mukherjee, Abhik; Nateri, Abdolrahman S
Repurposing antibacterial AM404 as a potential anticancer drug for targeting colorectal cancer stem-like cells Journal Article
In: Cancers (Basel), vol. 12, no. 1, pp. 106, 2019.
Abstract | Tags: AM404, cancer stem cells, colonosphere, CRC, Differentiation, drug screening, FBXL5 E3-ligase, patient derived organoids, resistance and metastasis, tissue explants
@article{Ahmed2019-eb,
title = {Repurposing antibacterial AM404 as a potential anticancer drug
for targeting colorectal cancer stem-like cells},
author = {Mehreen Ahmed and Nicholas Jinks and Roya Babaei-Jadidi and Hossein Kashfi and Marcos Castellanos-Uribe and Sean T May and Abhik Mukherjee and Abdolrahman S Nateri},
year = {2019},
date = {2019-12-01},
journal = {Cancers (Basel)},
volume = {12},
number = {1},
pages = {106},
publisher = {MDPI AG},
abstract = {Tumour-promoting inflammation is involved in colorectal cancer
(CRC) development and therapeutic resistance. However, the
antibiotics and antibacterial drugs and signalling that regulate
the potency of anticancer treatment upon forced differentiation
of cancer stem-like cell (CSC) are not fully defined yet. We
screened an NIH-clinical collection of the small-molecule
compound library of antibacterial/anti-inflammatory agents that
identified potential candidate drugs targeting CRC-SC for
differentiation. Selected compounds were validated in both in
vitro organoids and ex vivo colon explant models for their
differentiation induction, impediment on neoplastic cell growth,
and to elucidate the mechanism of their anticancer activity. We
initially focused on AM404, an anandamide uptake inhibitor.
AM404 is a metabolite of acetaminophen with antibacterial
activity, which showed high potential in preventing CRC-SC
features, such as stemness/de-differentiation, migration and
drug-resistance. Furthermore, AM404 suppressed the expression of
FBXL5 E3-ligase, where AM404 sensitivity was mimicked by
FBXL5-knockout. This study uncovers a new molecular mechanism
for AM404-altering FBXL5 oncogene which mediates
chemo-resistance and CRC invasion, thereby proposes to repurpose
antibacterial AM404 as an anticancer agent.},
keywords = {AM404, cancer stem cells, colonosphere, CRC, Differentiation, drug screening, FBXL5 E3-ligase, patient derived organoids, resistance and metastasis, tissue explants},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio